Interesting that baker young wont be able to pick up cheap...

Interesting that baker young wont be able to pick up cheap shares again?? I wonder if they will somehow get the opportunity to get clients in?


Suda a future cancer company and what it’s worth....

Edison group valued suda at 9 cents without TGA approval. So what is it worth now?

We are also due for Anagrelide results which will hopefully be positive and also you would think that a sumatriptan update isn’t far off?

Also in the background is the acquisition that should again add more value to suda.

What is a cancer company worth in phase 1 trials? Then add all the little extras suda have?

IMU in phase 2 = 280 mil market cap. This is in phase 2 though and suda don’t even have a drug yet but Paul hopper attached....

Suda currently $ 9 mil - next week 18 mil.



Zolpi + Anagrelide + sumatriptan + Sanofi deal + Ordesa deal....value?? = 30-45mil market cap maybe? (10-15 cents?) maybe even 20 depending on Anagrelide....?

Then plus 30 - 50 mil cancer drug. Obviously we pay for it but it can be partial now and then partial after phase 1 results.



I’m not a huge fan of zolpi but it will bring in money down the road. TGA approval is a big deal to this company because its a step forward. SC and MS only ever ran backwards.

Let’s hope there is a lot more to come. We havnt even hit the last CR price yet!